HONG KONG, June 5, 2026 /PRNewswire/ -- UniTrust Global Limited | UTGL announced a donation of HK$650,000 to Prime Healthcare Medical Services Limited in support of a clinical study on Enhanced External Counterpulsation (EECP). The donation reflects UTGL's long-term corporate vision of supporting local medical research, improving human health and well-being, and exploring cutting-edge anti-aging and regenerative technologies through corporate social responsibility.
The clinical study is titled "Efficacy and Dose-Response of Enhanced External Counterpulsation (EECP) on Blood Pressure in Pre-hypertension and Stage 1 Essential Hypertension: A Two-Phase, Randomized, Sham-Controlled Trial." It is expected to enrol 70 to 100 participants with pre-hypertension or Stage 1 essential hypertension and will adopt a two-phase, randomized, sham-controlled design to explore the potential impact and dose-response of EECP on blood pressure management. EECP is a non-invasive external therapy with established medical applications to improve blood flow and alleviate symptoms of chronic stable angina; its applicability and potential role in the study population require validation through rigorous clinical research.
